Hennebelle I - Search Results

1

Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children.

White-Koning M, Civade E, Geoerger B, Thomas F, Le Deley MC, Hennebelle I, Delord JP, Chatelut E, Vassal G. White-Koning M, et al. Among authors: hennebelle i. Clin Cancer Res. 2011 Jul 15;17(14):4862-71. doi: 10.1158/1078-0432.CCR-10-3278. Epub 2011 Jun 8. Clin Cancer Res. 2011. PMID: 21653689 Clinical Trial.

2

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma.

Thomas F, Rochaix P, White-Koning M, Hennebelle I, Sarini J, Benlyazid A, Malard L, Lefebvre JL, Chatelut E, Delord JP. Thomas F, et al. Among authors: hennebelle i. Eur J Cancer. 2009 Sep;45(13):2316-23. doi: 10.1016/j.ejca.2009.05.007. Epub 2009 Jun 10. Eur J Cancer. 2009. PMID: 19523815

3

Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinoma.

Thomas F, Delmar P, Vergez S, Rochaix P, Hennebelle I, McLoughlin P, Benlyazid A, Sarini J, Delord JP. Thomas F, et al. Among authors: hennebelle i. Head Neck. 2013 Jun;35(6):809-18. doi: 10.1002/hed.23036. Epub 2012 Jul 13. Head Neck. 2013. PMID: 22791662

4

Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: pharmacokinetic and pharmacodynamic evaluation.

Guichard S, Montazeri A, Chatelut E, Hennebelle I, Bugat R, Canal P. Guichard S, et al. Among authors: hennebelle i. Clin Cancer Res. 2001 Oct;7(10):3222-8. Clin Cancer Res. 2001. PMID: 11595718

5

Unexpected high levels of vorinostat when combined with vinorelbine in patients with advanced cancer.

Gandia P, Arellano C, Chalret du Rieu Q, Lochon I, Campone M, Pierga JY, Poublanc M, Hennebelle I, Filleron T, Chatelut E, Delord JP. Gandia P, et al. Among authors: hennebelle i. Curr Clin Pharmacol. 2011 Nov;6(4):274-9. doi: 10.2174/157488411798375921. Curr Clin Pharmacol. 2011. PMID: 22082325 Clinical Trial.

6

Dexamethasone as a probe for docetaxel clearance.

Puisset F, Chatelut E, Dalenc F, Busi F, Cresteil T, Azéma J, Poublanc M, Hennebelle I, Lafont T, Chevreau C, Roché H. Puisset F, et al. Among authors: hennebelle i. Cancer Chemother Pharmacol. 2004 Sep;54(3):265-72. doi: 10.1007/s00280-004-0823-0. Epub 2004 May 5. Cancer Chemother Pharmacol. 2004. PMID: 15133628 Clinical Trial.

7

Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin.

Sauzay C, White-Koning M, Hennebelle I, Deluche T, Delmas C, Imbs DC, Chatelut E, Thomas F. Sauzay C, et al. Among authors: hennebelle i. Pharmacol Res. 2016 Aug;110:89-95. doi: 10.1016/j.phrs.2016.05.012. Epub 2016 May 10. Pharmacol Res. 2016. PMID: 27178732

8

Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report.

Laurenty AP, Thomas F, Chatelut E, Bétrian S, Le Guellec C, Hennebelle I, Le Guellec S, Chevreau C. Laurenty AP, et al. Among authors: hennebelle i. Pharmacogenomics. 2013 Sep;14(12):1389-96. doi: 10.2217/pgs.13.124. Pharmacogenomics. 2013. PMID: 24024892

9

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.

Thomas F, Hennebelle I, Delmas C, Lochon I, Dhelens C, Garnier Tixidre C, Bonadona A, Penel N, Goncalves A, Delord JP, Toulas C, Chatelut E. Thomas F, et al. Among authors: hennebelle i. Clin Pharmacol Ther. 2016 Feb;99(2):235-42. doi: 10.1002/cpt.210. Epub 2015 Nov 10. Clin Pharmacol Ther. 2016. PMID: 26265035

10

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C. Balin-Gauthier D, et al. Among authors: hennebelle i. Cancer Chemother Pharmacol. 2006 Jun;57(6):709-18. doi: 10.1007/s00280-005-0123-3. Epub 2005 Dec 1. Cancer Chemother Pharmacol. 2006. PMID: 16320055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters